Clinical Trial Update: 18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating 18F-sodium fluoride PET as a replacement for bone scintigraphy, assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Disease
• Bone Cancer
• Infectious Disease

Drugs mentioned

• 18F-Sodium Fluoride (sodium fluoride (F-18))

Snippet

Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Conditions: Bone Cancer, Articular Disease | Phase 3 | Status: UNKNOWN